Skip to main content
. 2024 Jun 10;24(4):469–479. doi: 10.1007/s40256-024-00652-6

Fig. 3.

Fig. 3

Proposed algorithm for the use of vericiguat in older and complex patients. ARNI angiotensin receptor/neprilysin inhibitor, BB β-blockers, HF heart failure, HFrEF heart failure with reduced ejection fraction, MRA mineralocorticoid receptor antagonist, OMT optimal medical therapy, PDE-5 phosphodiesterase-5, RASi renin-angiotensin-aldosterone system inhibitors, SBP systolic blood pressure, SGLT2i sodium-glucose co-transporter-2 inhibitors, UTI urinary tract infection, WRF worsening renal function